In light of recent research which highlights the impact industry is having on scientific literature on the 3Rs (Replacement, Reduction and Refinement) principles of animal research, ABPI Policy Officer Nicola Platt considers the increased contribution and collaboration of industry towards reducing, refining and replacing animal testing in medicine development.Read more
Dr Virginia (Ginny) Acha has been appointed as the ABPI's new Executive Director - Research Medical and Innovation (RM&I). Dr Acha will take up the position at the beginning of March and report directly to ABPI Chief Executive Stephen Whitehead.Read more
ABPI and BIA welcomes publication of second case study showcasing the support Medicines and Healthcare products Regulatory Agency (MHRA) can offer medicines manufacturers in the UK.Read more
The National Audit Office’s (NAO) report Progress in improving cancer services and outcomes in England, published today, confirms that cancer patients in England have poorer access to life-saving and life-enhancing medicines than cancer patients across Europe adversely affecting their health outcomes and survival rates.Read more
Our website is not compatible with Internet Explorer 8. If you are experiencing problems with scrolling please upgrade to a later version or use another browser.